Consensus Theralase Technologies Inc.
Stocks
TLT
CA88337V1004
Advanced Medical Equipment & Technology
|
Market Closed -
Toronto S.E.
14:57:22 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 0.1750 CAD | 0.00% |
|
-5.41% | +6.06% |
| 09-15 | Theralase Technologies Commences GLP Toxicology Analysis of Rutherrin | CI |
| 08-28 | Theralase Technologies Inc., Q1 2026 Earnings Call, Jun 09, 2026 |
Evolution of the Average Target: Theralase Technologies Inc.
Evolution of the Target Price: Theralase Technologies Inc.
Changes in Analyst Recommendations: Theralase Technologies Inc.
05e700c41c1d979952f47.1Jui4uJt-NDgKSwWFOIvT0SuvL4EN-6PwP7Jn7G-WxQ.hO3s1bIcsJ6nZkdXZNJZKX36-MdoRNjMppSn5YDVGme3ouGRjhfVo9VOeQ~637ffea762ace8e89cf9d73aa535773a


Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1750CAD
Average target price
0.7000CAD
Spread / Average Target
+300.00%
High Price Target
0.7000CAD
Spread / Highest target
+300.00%
Low Price Target
0.7000CAD
Spread / Lowest Target
+300.00%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- TLT Stock
- Consensus Theralase Technologies Inc.
Select your edition
All financial news and data tailored to specific country editions
















